Speaker Profile
Biography
Dr. Kurzrock is a boardcertified medical oncologist and a renowned expert in precision medicine. She developed one of the worlds largest Phase I clinical trial programs while at MD Anderson Cancer Center. Dr. Kurzrock also founded the UCSDs Center for Personalized Cancer Therapy, focusing on genomicallydriven therapy as well as precision immunotherapy, especially in rare cancers. Dr. Kurzrock brought the first transcriptomic study to the clinic in an international setting spanning five countries (WINTHER), as well as the first Nof1 study of individually customized combination therapy (IPREDICT). Dr. Kurzrock received her MD from the University of Toronto, Canada. She has 900 PubMed publications, an Hindex of 140, has been named to the lists of most highly cited scientists in the world. She has a uniquely strong record of competitive funding with 100 million dollars in lifetime funding, and has overseen early development of multiple drugs that are now FDA approved.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Mark Daly, Broad Institute (implied from context, but you didn’t restate – leaving just content here as requested)
PMWC Award Ceremony
• Mark Daly, Broad Institute
• Gordon Sanghera, Oxford Nanopore
The Data Factory: Building Systems to Integrate Millions of Genomes for Variant Interpretation
• Chair: Stephen B. Montgomery, Stanford
• Carlos D. Bustamante, University of Oklahoma
• Mark Daly, Broad Institute/FinnGen
• Manuel Rivas, Stanford
• Mark McCarthy, Genentech
• Nilah Ioannidis, UC Berkeley/UCSC
Beyond the Read: Integrating Long-Read Data into the Clinical Variant Pipeline
• Chair: Gordon Sanghera, Oxford Nanopore Technologies
• Hanlee P. Ji, Stanford
• Barrett Bready, Nabsys
Keynote: Biobanks and the Road Ahead in Human Genetics
• Mark Daly, Broad Institute/FinnGen
AI and Evolution for Predicting Human Disease Genes
• Chair: Yuval Tabach, Hebrew University
• Nilah Ioannidis, UC Berkeley/UCSC
• Sasa Jenko, European Commission
DNA to Drug, Label & Coverage: From Genetic Signals to Approval & Access
• Chair: Razelle Kurzrock, Medical College of Wisconsin
• Russ B Altman, Stanford
• Slavé Petrovski, AstraZeneca
• Wei Zhou, Broad Institute
25+ Years of the Human Genome — From Bench to Bedside to Beyond
• Chair: Ralph Snyderman, Duke
• J. Craig Venter, Craig Venter Institute (JCVI)
• Brook Byers, KPCB
• Lee Hood, Phenome Health




